← FDA DRUG APPROVALS

FDA NDA · NDA006525

GANTRISIN

Sponsor: ROCHE

APPLICATION
NDA006525
TYPE
NDA
ORIGINAL APPROVAL
1948-07-29
LATEST ACTION
1997-01-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

GANTRISINDiscontinued
SULFISOXAZOLE 500MG · TABLET · ORAL

Approval history

1997-01-09Labeling · Supplement 18AP
1993-08-04Labeling · Supplement 20AP
1982-05-25Labeling · Supplement 17AP
1978-07-12Labeling · Supplement 16AP
1978-01-27Labeling · Supplement 15AP
1948-07-29UNKNOWN · Original · unknownAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →